iCAD Takes Aim At R2 Technology With $30 Mil. CADx Acquisition
This article was originally published in The Gray Sheet
Executive Summary
iCAD will deepen its computer-assisted detection portfolio by developing applications for CADx' Second Look platform to identify cardiovascular disease and lung and colon cancers
You may also be interested in...
R2 ImageChecker Approval Launches CAD Lung Market; iCAD Preps To Join
FDA approval of R2 Technology's ImageChecker CT CAD system for lung nodules July 8 provides the firm with a comfortable head-start over competitor iCAD, which expects to launch its own system in 2005
R2 ImageChecker Approval Launches CAD Lung Market; iCAD Preps To Join
FDA approval of R2 Technology's ImageChecker CT CAD system for lung nodules July 8 provides the firm with a comfortable head-start over competitor iCAD, which expects to launch its own system in 2005
iCAD To Launch Lung, Colon CAD Indications In U.S. By Year-End
iCAD, Inc. plans an "aggressive" ClickCAD fee-per-procedure program roll-out in July to low-volume mammography centers